查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1998686

体外循环机市场商机、成长要素、产业趋势分析及2026-2035年预测。

Heart-lung Machine Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
出版日期: | 出版商: Global Market Insights Inc. | 英文 120 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球心肺体外迴圈装置市场预计到 2025 年将达到 3.853 亿美元，年复合成长率为 4.7%，到 2035 年将达到 6.067 亿美元。

体外循环机市场-IMG1

市场扩张的主要驱动力是心血管疾病盛行率的上升以及全球器官移植和心臟手术数量的增加。心肺体外迴圈机（CPB），也称为心肺体外迴圈装置，在手术期间透过为血液供氧、清除二氧化碳和维持循环，暂时取代心臟和肺部的功能。氧合系统的改良和先进血泵的设计等技术创新提高了效率、安全性和易用性。如今，紧凑型高性能设备能够实现更精确的循环控制，从而减少手术併发症，并使其在各种医疗环境中得到更广泛的应用。对微创手术日益增长的需求，以及手术全期疗效的改善，持续推动体外循环机在全球的应用。此外，保险报销制度的完善、门诊手术设施的扩建以及主要企业的策略投资也为市场的稳定成长提供了支持。

市场范围
开始年份 2025
预测期 2026-2035
初始市场规模 3.853亿美元
预测金额 6.067亿美元
复合年增长率 4.7%

单滚轮泵浦市场预计将以4.4%的复合年增长率成长，到2035年达到3.54亿美元。其受欢迎的原因在于可靠、可控的血流、成本效益以及在心血管手术中的广泛应用。这些帮浦是医院和新兴医疗机构的首选，因为它们能够提供稳定的体外膜氧合（ECMO），这对于需要长时间循环的手术至关重要。

预计到 2035 年，门诊手术中心市场规模将达到 2.43 亿美元，年复合成长率为 5.3%，而 2025 年的市场规模为 1.456 亿美元。该市场的成长主要得益于门诊微创心血管手术的日益普及，以及支持高效手术全期护理的紧凑、经济高效的心肺体外迴圈设备解决方案。

美国心肺体外迴圈）设备市场预计到 2025 年将达到 1.446 亿美元，并在 2026 年至 2035 年期间以 4.1% 的复合年增长率成长。每年大量的心血管手术、有利的报销政策、大量的研发投入以及主要製造商的存在，巩固了美国作为心肺体外迴圈设备领先市场的地位。

目录

第一章：调查方法

  • 研究途径
  • 品质改进计划
    • GMI人工智慧政策和资料完整性倡议
      • 资讯来源一致性通讯协定
  • 调查过程和可靠性评分
    • 调查过程的组成部分
    • 评分组成部分
  • 数据收集
    • 主要来源部分列表
  • 资料探勘资讯来源
    • 付费资讯来源
      • 区域资讯来源
  • 基本估算和计算方法
    • 每种方法中基准年的计算
  • 预测模型
    • 量化市场影响分析
      • 生长参数对预测的数学影响
  • 关于调查透明度的补充信息
    • 资讯来源归属框架
    • 品质保证指标
    • 对信任的承诺

第二章执行摘要

第三章业界考察

  • 生态系分析
  • 影响产业的因素
    • 促进因素
      • 心血管疾病盛行率增加
      • 器官移植手术数量增加
      • 体外循环机的技术进步
      • 老年人口增加
    • 产业潜在风险与挑战
      • 先进的心肺体外迴圈设备高成本
      • 替代疗法和微创手术的可及性
    • 市场机会
      • 器官移植计画的扩展增加了对先进灌注系统的需求。
  • 成长潜力分析
  • 监理情势
    • 北美洲
    • 欧洲
    • 亚太地区
  • 科技趋势
    • 当前技术趋势
    • 新兴技术
  • 未来市场趋势（基于初步研究）
  • 价格分析（2025 年）（基于初步调查）
  • 人工智慧和生成式人工智慧对市场的影响
  • 客户洞察（基于初步研究）
  • 波特五力分析
  • PESTEL 分析
  • 差距分析

第四章 竞争情势

  • 介绍
  • 企业矩阵分析
  • 企业市占率分析
    • 世界
    • 北美洲
    • 欧洲
    • 亚太地区
  • 竞争定位矩阵
  • 主要市场公司的竞争分析
  • 主要进展
    • 併购
    • 伙伴关係与合作
    • 新产品类型发布
    • 业务拓展计划

第五章 市场估计与预测：依类型划分，2022-2035年

  • 单辊泵
  • 双滚轮泵

第六章 市场估计与预测：依应用领域划分，2022-2035年

  • 心血管手术
  • 肺部手术
  • 急性呼吸衰竭的治疗
  • 其他用途

第七章 市场估计与预测：依最终用途划分，2022-2035年

  • 医院和诊所
  • 门诊手术中心
  • 其他最终用户

第八章 市场估计与预测：依地区划分，2022-2035年

  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国

第九章：公司简介

  • BRAILE
  • Edwards
  • ELITE LIFE CARE
  • EUROSETS
  • FRESENIUS MEDICAL CARE
  • GETINGE
  • HEART CARE INDIA CO
  • hemovent
  • Jarvik HEART
  • LivaNova
  • Medtronic
  • NIPRO
  • Palex
  • Philips
  • raumedic
  • TERUMO
简介目录
Product Code: 6060

The Global Heart-lung Machine Market was valued at USD 385.3 million in 2025 and is estimated to grow at a CAGR of 4.7% to reach USD 606.7 million by 2035.

Heart-lung Machine Market - IMG1

The market expansion is driven primarily by the rising prevalence of cardiovascular diseases and the increasing number of organ transplants and open-heart surgeries worldwide. Heart-lung machines, also referred to as cardiopulmonary bypass (CPB) devices, temporarily assume the functions of the heart and lungs during surgery by oxygenating blood, removing carbon dioxide, and maintaining circulation. Technological innovations, including improved oxygenator systems and advanced blood pump designs, have enhanced efficiency, safety, and usability. Compact and high-performance devices are now enabling more precise circulation control, reduced surgical complications, and broader adoption in diverse healthcare settings. The growing demand for minimally invasive procedures, coupled with improved perioperative outcomes, continues to propel the use of heart-lung machines globally. Additionally, better reimbursement frameworks, expanding outpatient surgical facilities, and strategic investments by key players are supporting steady market growth.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$385.3 Million
Forecast Value$606.7 Million
CAGR4.7%

The single roller pump segment is expected to grow at a CAGR of 4.4% to reach USD 354 million by 2035. Its popularity stems from reliable, controlled blood flow, cost-effectiveness, and widespread use in cardiac surgeries. These pumps offer stable extracorporeal membrane oxygenation, which is crucial for procedures requiring prolonged circulation, making them a preferred choice across hospitals and emerging healthcare facilities.

The ambulatory surgical centers segment accounted for USD 145.6 million in 2025 and is projected to reach USD 243 million by 2035, growing at a CAGR of 5.3%. Growth in this segment is fueled by the increasing adoption of minimally invasive cardiac procedures in outpatient settings, alongside compact, cost-efficient heart-lung machine solutions that support efficient perioperative care.

U.S. Heart-lung Machine Market reached USD 144.6 million in 2025 and is expected to grow at a CAGR of 4.1% from 2026 to 2035. High annual cardiac surgery volumes, favorable reimbursement policies, substantial R&D investment, and the presence of major manufacturers strengthen the U.S. position as a leading market for heart-lung machines.

Prominent players operating in the Global Heart-lung Machine Market include BRAILE, Edwards, ELITE LIFE CARE, EUROSETS, FRESENIUS MEDICAL CARE, GETINGE, HEART CARE INDIA CO, Hemovent, Jarvik HEART, LivaNova, Medtronic, NIPRO, Palex, Philips, Raumedic, and TERUMO. Key strategies adopted by companies in the Global Heart-lung Machine Market include continuous R&D for advanced oxygenation and pump technologies, development of compact and portable devices for outpatient facilities, strategic partnerships with hospitals and surgical centers, expansion of global distribution networks, and ensuring regulatory compliance across multiple regions. Firms also focus on offering training programs, technical support, and after-sales services to improve adoption and customer loyalty, while optimizing production efficiency and supply chains to enhance competitiveness and market penetration.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Research approach
  • 1.2 Quality commitments
    • 1.2.1 GMI AI policy & data integrity commitment
      • 1.2.1.1 Source consistency protocol
  • 1.3 Research trail & confidence scoring
    • 1.3.1 Research trail components
    • 1.3.2 Scoring components
  • 1.4 Data collection
    • 1.4.1 Partial list of primary sources
  • 1.5 Data mining sources
    • 1.5.1 Paid sources
      • 1.5.1.1 Sources, by region
  • 1.6 Base estimates and calculations
    • 1.6.1 Base year calculation for any one approach
  • 1.7 Forecast model
    • 1.7.1 Quantified market impact analysis
      • 1.7.1.1 Mathematical impact of growth parameters on forecast
  • 1.8 Research transparency addendum
    • 1.8.1 Source attribution framework
    • 1.8.2 Quality assurance metrics
    • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Type trends
    • 2.2.3 Application
    • 2.2.4 End use trends
  • 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of cardiovascular disease
      • 3.2.1.2 Growing number of organ transplant surgeries
      • 3.2.1.3 Technological advancements in heart-lung machines
      • 3.2.1.4 Rising geriatric population base
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of advanced heart-lung machines
      • 3.2.2.2 Availability of alternative and minimally invasive procedures
    • 3.2.3 Market opportunities
      • 3.2.3.1 Expansion of transplant programs boosting requirements for advanced perfusion systems
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
  • 3.5 Technology landscape
    • 3.5.1 Current technological trends
    • 3.5.2 Emerging technologies
  • 3.6 Future market trends (Driven by Primary Research)
  • 3.7 Pricing analysis, 2025 (Driven by Primary Research)
  • 3.8 Impact of AI and generative AI on the market
  • 3.9 Customer insights (Driven by Primary Research)
  • 3.10 Porter's analysis
  • 3.11 PESTEL analysis
  • 3.12 Gap analysis

Chapter 4 Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
    • 4.3.1 Global
    • 4.3.2 North America
    • 4.3.3 Europe
    • 4.3.4 Asia Pacific
  • 4.4 Competitive positioning matrix
  • 4.5 Competitive analysis of major market players
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New product type launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Type, 2022 - 2035 ($ Mn)

  • 5.1 Key trends
  • 5.2 Single roller pump
  • 5.3 Double roller pump

Chapter 6 Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

  • 6.1 Key trends
  • 6.2 Cardiac surgeries
  • 6.3 Lung surgeries
  • 6.4 Acute respiratory failure treatment
  • 6.5 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals and clinics
  • 7.3 Ambulatory surgical centers
  • 7.4 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 BRAILE
  • 9.2 Edwards
  • 9.3 ELITE LIFE CARE
  • 9.4 EUROSETS
  • 9.5 FRESENIUS MEDICAL CARE
  • 9.6 GETINGE
  • 9.7 HEART CARE INDIA CO
  • 9.8 hemovent
  • 9.9 Jarvik HEART
  • 9.10 LivaNova
  • 9.11 Medtronic
  • 9.12 NIPRO
  • 9.13 Palex
  • 9.14 Philips
  • 9.15 raumedic
  • 9.16 TERUMO